ISIN | CH0118503355 |
---|---|
Valor Number | 11850335 |
Bloomberg Global ID | |
Fund Name | Equity Switzerland Optimized ESG IR |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 75 01 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The fund offers investors in Swiss equities an efficient alternative to traditional index weighting. Taking account of the limited marketability of most Swiss equities, an optimally diversified portfolio is compiled as part of a systematic, disciplined investment process; this portfolio improves the risk-return ratio of the SPI. |
Peculiarities |
Current Price * | 2,705.28 CHF | 09.10.2025 |
---|---|---|
Previous Price * | 2,693.74 CHF | 08.10.2025 |
52 Week High * | 2,791.96 CHF | 26.05.2025 |
52 Week Low * | 2,453.66 CHF | 20.12.2024 |
NAV * | 2,705.28 CHF | 09.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 219,801,853 | |
Unit/Share Assets *** | 219,801,853 | |
Trading Information SIX |
YTD Performance | +8.58% |
30.12.2024 - 09.10.2025
30.12.2024 09.10.2025 |
---|---|---|
1 month | +0.21% |
09.09.2025 - 09.10.2025
09.09.2025 09.10.2025 |
3 months | -0.95% |
09.07.2025 - 09.10.2025
09.07.2025 09.10.2025 |
6 months | +8.91% |
09.04.2025 - 09.10.2025
09.04.2025 09.10.2025 |
1 year | +2.30% |
09.10.2024 - 09.10.2025
09.10.2024 09.10.2025 |
2 years | +14.56% |
09.10.2023 - 09.10.2025
09.10.2023 09.10.2025 |
3 years | +23.36% |
10.10.2022 - 09.10.2025
10.10.2022 09.10.2025 |
5 years | +12.57% |
09.10.2020 - 09.10.2025
09.10.2020 09.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 8.49% | |
---|---|---|
Novartis AG Registered Shares | 8.42% | |
Roche Holding AG | 5.59% | |
Galenica Ltd | 4.67% | |
PSP Swiss Property AG | 4.22% | |
Swisscom AG | 4.16% | |
Chocoladefabriken Lindt & Spruengli AG Ordinary Shares - Non Voting | 4.13% | |
Swiss Prime Site AG | 4.00% | |
Givaudan SA | 3.71% | |
SGS AG | 3.65% | |
Last data update | 30.04.2025 |
TER | 0.69% |
---|---|
TER date | 31.08.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.64% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |